Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

Susan Bernstein  |  Issue: February 2016  |  February 16, 2016

At the end of glycolysis, glucose is converted to pyruvate. Th17 cells drive pyruvate oxidation, said Dr. Rathmell. Pyruvate dehydrogenase kinase (PDHK) and dichloroacetate (DCA) selectively affect the Th17 and T-regulatory CD4 subsets. Glycolysis is sort of a “metabolic switch” where we see different T cells either increase or decrease.

“Clinically, it is still to be determined how much metabolic pathways can be manipulated, but things we are doing are affecting those pathways, and that’s why we have the outcomes,” he said. “Different cell types have different abilities to adapt,” so interventions like ketogenic diets may one day be used to manipulate metabolic pathways. “If nutrients outside cells change, then cells have to change to cope, but we don’t yet understand the connections.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Oxygen Supply

According to Dr. Veale, although glucose may fuel some of the metabolic pathways involved in inflammation, oxygen is another driving force. “If you were sitting on top of a mountain right now, you’d be hypoxic and feel dizzy, nauseous and have a headache,” he told the audience at the sea-level conference. “Our cells’ ability to deal with hypoxia has evolved over billions of years.”

Dr. Veale also said that hypoxia plays a role in angiogenesis in early inflammatory arthritis. Cells can move across the endothelial membrane. The protein VEGF is stimulated by low levels of oxygen during this process. “As oxygen levels go up, they form a tight association between pericytes and endothelial cells,” which signals transcription. VEGF plays a role in RA, for example, making endothelial cells more permeable and stimulating angiogenesis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

According to Dr. Veale, you might see blood vessels at different levels of maturity in a hypoxic joint in RA. This allows for the egress of inflammatory cells. In inflammatory arthritis, blood vessel function is not normal. In joints affected by osteoarthritis, there is mature vasculature. Where there is inflammation, such as in psoriasis with active skin disease, we see immature vasculature that improves after treatment.

VEGF and another protein, Ang2, are found in high levels in synovial fluid of inflamed joints, and they induce Notch-1 signaling in endothelial cells. Notch-1 also mediates VEGF- and Ang2-induced angiogenesis, and it increases the effect of these proteins.

Hypoxia can be seen in some samples of inflamed synovial tissue. In fact, some levels of pO2 are extremely low in some patients’ tissue, and in cases of severe inflammation, there are many immature blood vessels. As oxygen levels go up, blood vessels in inflamed tissue begin to look more normal, he said.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)inflammationinflammatorymetabolicpathwaysResearchRheumatic Diseaserheumatologysignaling

Related Articles

    Harder to Breathe: The Infrastructure Behind Medical Oxygen

    January 10, 2022

    Last year, in Texas, they had no room to breathe. Texas has 301 designated trauma centers equipped to provide intensive care, 200 of which can care for at least four critically ill patients. In August 2021, 75 of these hospitals reported having no available beds in their intensive care units. Zero. This was due, in…

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

    Researchers Find the Switch that Underlies Macrophage Metabolism

    March 28, 2016

    During pro-inflammatory stimulation, a recent study found HIF1α—not Myc—is required for the regulation of glycolysis in macrophages. Researchers examined macrophages and the distinct transcriptional programs engaged in response to mitogenic and pro-inflammatory stimulation…

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences